Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Context Therapeutics Inc (NQ: CNTX ) 2.290 -0.210 (-8.40%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Context Therapeutics Inc < Previous 1 2 3 4 5 Next > 12 Health Care Stocks Moving In Friday's After-Market Session August 04, 2023 Via Benzinga Context Therapeutics to Participate in Two August 2023 Investor Conferences August 01, 2023 From Context Therapeutics Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session July 19, 2023 Via Benzinga ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer June 08, 2023 This year’s 2023 American Society of Clinical Oncology Annual Meeting (ASCO 2023) provided a surprising amount of clinical data relevant to biopharma investors. Via Benzinga Traders Insights: These Biotech Stocks On Radar: VSTM, SNTX, CGEN, SONN June 05, 2023 Via AB Newswire Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 05, 2023 Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. Via Benzinga Context Therapeutics Reports First Quarter 2023 Operating and Financial Results May 10, 2023 From Context Therapeutics Inc. Via GlobeNewswire Significant Unmet Need In Solid Tumors Reported, And How Context Therapeutics (NASDAQ:CNTX) Plans To Make A Difference April 18, 2023 Via ACCESSWIRE Significant Unmet Need In Solid Tumors Reported, And How Context Therapeutics (NASDAQ: CNTX) Plans To Make A Difference April 14, 2023 Context Therapeutics Inc. (NASDAQ: CNTX) is a biopharmaceutical company committed to advancing medicines for solid tumors by harnessing novel and innovative treatment targets such as Claudin 6... Via Benzinga Context Therapeutics to Participate in Two April 2023 Investor Conferences April 03, 2023 From Context Therapeutics Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023 March 23, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 23, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday March 23, 2023 We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning! Via InvestorPlace Context Therapeutics Reports Full Year 2022 Financial Results and Recent Pipeline Updates March 22, 2023 From Context Therapeutics Inc. Via GlobeNewswire Context Therapeutics Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2023 March 15, 2023 Context to host webinar with AACR presenter on Monday, April 17, 2023, at 4:30 p.m. ET From Context Therapeutics Inc. Via GlobeNewswire $7M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying February 22, 2023 The Dow Jones closed lower by around 700 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Context Therapeutics And 3 Other Stocks Under $2 Insiders Are Aggressively Buying February 14, 2023 The Dow Jones closed higher by more than 370 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Insiders Buying AmeriServ Financial And 2 Other Penny Stocks February 07, 2023 The Dow Jones dropped by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in... Via Benzinga Context Therapeutics Highlights Clinical Responses from the Phase 2 OATH Clinical Trial Evaluating ONA-XR for the Treatment of Endometrial Cancer February 06, 2023 From Context Therapeutics Inc. Via GlobeNewswire Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket February 01, 2023 Gainers Via Benzinga Tesla, Amazon, Apple, Context Therapeutics, Snap: Why These 5 Stocks Are Drawing Investors' Attention Today January 31, 2023 Major Wall Street indices closed over 1% higher on Tuesday, led by upbeat corporate earnings and expectations that the Federal Reserve will slow down its rate hike pace as the centr Via Benzinga Dow Surges Over 200 Points; Pfizer Issues Weak Forecast January 31, 2023 U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Tuesday. The Dow traded up 0.63% to 33,931.13 while the NASDAQ rose 1.20% to 11,529.99. The S&P... Via Benzinga Why Context Therapeutics (CNTX) Shares Are Seeing Blue Skies January 31, 2023 Context Therapeutics Inc (NASDAQ: CNTX) shares are trading higher by 60.32% to $1.10 Tuesday afternoon after the company announced its clinical trial collaborator, Stemline Therapeutics, received... Via Benzinga Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 31, 2023 Gainers Via Benzinga Dow Turns Higher; Nasdaq Jumps 100 Points January 31, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Tuesday. The Dow traded up 0.19% to 33,781.23 while the NASDAQ rose 0.90% to 11,496.13. The S&P... Via Benzinga Context Therapeutics’ Clinical Partner Stemline Therapeutics, a Subsidiary of Menarini Group Receives FDA Approval of ORSERDU™ (elacestrant) in ER+, HER2-, ESR1-mutated Breast Cancer January 31, 2023 From Context Therapeutics Inc. Via GlobeNewswire $1 Million Bet On Motorsport Games? Check Out These 4 Penny Stocks Insiders Are Buying January 31, 2023 The Nasdaq dropped more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in... Via Benzinga Context Therapeutics And 3 Other Stocks Under $1 Insiders Are Aggressively Buying January 24, 2023 The Dow Jones closed higher by more than 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Myomo, Enzo Biochem And These 2 Stocks Under $2 Insiders Are Aggressively Buying January 19, 2023 The Dow Jones closed lower by more than 600 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Context Therapeutics and Lonza Enter Manufacturing Agreement for Bispecific Antibody Targeting Claudin 6-Positive Cancers January 09, 2023 From Context Therapeutics Inc. Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.